🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this study is to demonstrate the efficacy of an inve...
Status
Completed
Location
Multiple Locations
Start Date
2007-11
Trial ID
NCT00566345
The present study will evaluate clinical efficacy, safety, tolerability and...
Status
Completed
Location
Site 14
Start Date
2007-10
Trial ID
NCT00630331
Treatments Being Tested
The purpose of this study is to compare immunogenicity and safety of ASP737...
Status
Completed
Location
Multiple Locations
Start Date
2012-10
Trial ID
NCT01767896
Treatments Being Tested
The purpose of this study is to describe the immunogenicity and safety of t...
Status
Completed
Location
Multiple Locations
Start Date
2013-09
Trial ID
NCT02344134
Treatments Being Tested
Evaluate safety and tolerability of TIVa or TIVb vaccine in healthy childre...
Status
Completed
Location
320, Novartis Investigational Site
Start Date
2013-05
Trial ID
NCT01857206
Treatments Being Tested
Immunogenicity and safety of a cell-derived influenza vaccine in adults age...
Status
Completed
Location
Site Reference ID/Investigator# 45690
Start Date
2009-05
Trial ID
NCT00889889
Treatments Being Tested
The purpose of this study is to evaluate the safety and immunogenicity of c...
Status
Completed
Location
Multiple Locations
Start Date
2005-10
Trial ID
NCT00264576
Treatments Being Tested
This Phase 3 study evaluates the safety, immunogenicity and lot-to lot cons...
Status
Completed
Location
Optimal Research, LLC
Start Date
2016-07-11
Trial ID
NCT02839330
The study primarily aims to evaluate immunogenicity and safety of influenza...
Status
Completed
Location
5
Start Date
2007-10
Trial ID
NCT00579345
This study is a multi-center, randomized, double-blind Phase III clinical t...
Status
Completed
Location
Multiple Locations
Start Date
2014-09
Trial ID
NCT02621164
Treatments Being Tested